Biology Reference
In-Depth Information
Trujillo, J. R., Rogers, R., Molina, R. M., Dangond, F., McLane, M. F., Essex, M., and Brain, J. D.
(2007). Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the
mannose receptor. Proc. Natl. Acad. Sci. USA 104, 5097-5102.
Turner, A., Bruun, B., Minson, T., and Browne, H. (1998). Glycoproteins gB, gD, and gHgL of herpes
simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell
transfection system. J. Virol. 72, 873-875.
Ugolini, S., Mondor, I., and Sattentau, Q. J. (1999). HIV-1 attachment: another look. Trends
Microbiol. 7, 144-149.
Ujike, M., Nishikawa, H., Otaka, A., Yamamoto, N., Matsuoka, M., Kodama, E., Fujii, N., and
Taguchi, F. (2008). Heptad repeat-derived peptides block protease-mediated direct entry from the
cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal
pathway.
J. Virol. 82, 588-592.
Umashankar, M., Sanchez San Martin, C., Liao, M., Reilly, B., Guo, A., Taylor, G., and Kielian, M.
(2008). Differential Cholesterol Binding by Class Ii Fusion Proteins Determines Membrane
Fusion Properties.
.
Vaillancourt, F. H., Pilote, L., Cartier, M., Lippens, J., Liuzzi, M., Bethell, R. C., Cordingley, M. G.,
and Kukolj, G. (2009). Identification of a lipid kinase as a host factor involved in hepatitis C virus
RNA replication.
J. Virol
Virology 387, 5-10.
Vasiljeva, O., Reinheckel, T., Peters, C., Turk, D., Turk, V., and Turk, B. (2007). Emerging roles of
cysteine cathepsins in disease and their potential as drug targets.
Curr. Pharm. Des. 13, 387-403.
Vincent, M. J., Sanchez, A. J., Erickson, B. R., Basak, A., Chretien, M., Seidah, N. G., and
Nichol, S. T. (2003). Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing
by subtilase SKI-1.
J. Virol. 77, 8640-8649.
Wallin, M., Ekstrom, M., and Garoff, H. (2004). Isomerization of the intersubunit disulphide-bond in
Env controls retrovirus fusion.
EMBO J. 23, 54-65.
Wang, H., Yang, P., Liu, K., Guo, F., Zhang, Y., Zhang, G., and Jiang, C. (2008). SARS coronavirus
entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell
Res. 18, 290-301.
Watson, D. J., Kobinger, G. P., Passini, M. A., Wilson, J. M., and Wolfe, J. H. (2002). Targeted
transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola,
Mokola, LCMV, or MuLV envelope proteins. Mol. Ther. 5, 528-537.
Weissenhorn, W., Hinz, A., and Gaudin, Y. (2007). Virus membrane fusion. FEBS Lett. 581,
2150-2155.
Wengler, G. (1989). Cell-associated West Nile flavivirus is covered with E+pre-M protein hetero-
dimers which are destroyed and reorganized by proteolytic cleavage during virus release. J. Virol.
63, 2521-2526.
Wild, C., Greenwell, T., and Matthews, T. (1993). A synthetic peptide from HIV-1 gp41 is a potent
inhibitor of virus-mediated cell-cell fusion.
AIDS Res. Hum. Retroviruses 9, 1051-1053.
Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., and Matthews, T. J. (1994). Peptides
corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41
are potent inhibitors of virus infection.
Proc. Natl. Acad. Sci. USA 91, 9770-9774.
Wilk, T., Pfeiffer, T., and Bosch, V. (1992). Retained in vitro infectivity and cytopathogenicity of
HIV-1 despite truncation of the C-terminal tail of the env gene product.
Virology 189, 167-177.
Wong, L. F., Azzouz, M., Walmsley, L. E., Askham, Z., Wilkes, F. J., Mitrophanous, K. A.,
Kingsman, S. M., and Mazarakis, N. D. (2004). Transduction patterns of pseudotyped lentiviral
vectors in the nervous system.
Mol. Ther. 9, 101-111.
Wong, A. C., Sandesara, R. G., Mulherkar, N., Whelan, S. P., and Chandran, K. (2010). A forward
genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its
protease dependence during cell entry.
J. Virol. 84, 163-175.
